Etoposide
Who holds supplier records for Etoposide? 7 organisations hold a current record for Etoposide: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (3), India (1), Japan (1) and Netherlands (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Etoposide: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/etoposide
Reading the evidence
- 7 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 5 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (7)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Etoposide. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 10642 · latest filing Dec 1993
- JIANGSU HENGRUI PHARMACEUTICALS CO LTDChinaCEP Company GMP cert on recordActive DMF 8647 · latest filing Jul 1990
- Nippon Kayaku Co., Ltd.JapanCEP Company GMP cert on recordActive DMF 8946 · latest filing Jan 1991
- Shandong Anhong Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 41308 · latest filing Feb 2025
- TAPI NL BVNetherlandsCEPActive DMF 9966 · latest filing Nov 1992
- Sichuan Huiyu Pharmaceutical Co., Ltd.China Company GMP cert on recordActive DMF 40928 · latest filing Mar 2025
- MAC CHEM PRODUCTS INDIA PVT LTDCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (6)
Certificates of Suitability on the EDQM register for Etoposide, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| TAPI NL B.V. Amsterdam | NL | CEP 1999-144 - Rev 09 Etoposide | Mar 2026 | — |
| SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou | CN | CEP 2025-052 - Rev 00 Etoposide | Feb 2026 | Inspected Nov 2025 Greece |
| MAC CHEM PRODUCTS (INDIA) PRIVATE LIMITED Mumbai | IN | CEP 2020-074 - Rev 02 Etoposide | Apr 2025 | — |
| CIPLA LIMITED Mumbai | IN | CEP 2007-061 - Rev 06 Etoposide | Sept 2024 | — |
| JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. Lianyungang | CN | CEP 2008-037 - Rev 05 Etoposide | Oct 2023 | — |
| NIPPON KAYAKU CO., LTD. Tokyo | JP | R1-CEP 2004-003 - Rev 03 Etoposide | Aug 2015 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (6)
Organisations whose Type II DMFs for Etoposide are no longer active. These show a past filing, not current supply.
Show all 6 historical records
- China · Inactive DMF 38779 · filed Sept 2023
- China · Inactive DMF 24332 · filed Oct 2010
- PHARMACEUTICAL FACTORY SHANGHAI INSTITUTE PHARMACEUTICAL INDUSTRYInactive DMF 10191 · filed Apr 1993
- PLANTEX LTD CHEMICAL AND PHARMACEUTICAL WORKSInactive DMF 9546 · filed Feb 1992
- OMNICHEM NVInactive DMF 8696 · filed Aug 1990
- SANDOZ LTD PHARMACEUTICAL DIV CHEMICAL DEVELOPMENTInactive DMF 4385 · filed Nov 1981
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Etoposide is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL44657).
Chemical identity
- IUPAC name
- (5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one
- Canonical SMILES
- C[C@@H]1OC[C@@H]2[C@@H](O1)[C@@H]([C@H]([C@@H](O2)O[C@H]3[C@H]4COC(=O)[C@@H]4[C@@H](C5=CC6=C(C=C35)OCO6)C7=CC(=C(C(=C7)OC)O)OC)O)O
- InChIKey
- VJJPUSNTGOMMGY-MRVIYFEKSA-N
- Synonyms
- Etoposide, Etoposide resolution mixture, Etoposido, Etoposidum, NSC-141540, Sintopozid, Toposar, Vepesid, VP-16-213, trans-Etoposide, (-)-Etoposide, Lastet
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Topoisomerase Inhibitor
- Mechanism of action
- Topoisomerase Inhibitors
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Etoposide?
7 organisations hold an active US FDA Type II Drug Master File or a CEP for Etoposide: Cipla Limited (India), JIANGSU HENGRUI PHARMACEUTICALS CO LTD (China), Nippon Kayaku Co., Ltd. (Japan), Shandong Anhong Pharmaceutical Co., Ltd. (China), TAPI NL BV (Netherlands), Sichuan Huiyu Pharmaceutical Co., Ltd. (China) and MAC CHEM PRODUCTS INDIA PVT LTD. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Etoposide Drug Master Files are active?
Cipla Limited (DMF 10642), JIANGSU HENGRUI PHARMACEUTICALS CO LTD (DMF 8647), Nippon Kayaku Co., Ltd. (DMF 8946), Shandong Anhong Pharmaceutical Co., Ltd. (DMF 41308), TAPI NL BV (DMF 9966) and Sichuan Huiyu Pharmaceutical Co., Ltd. (DMF 40928). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Etoposide records mean?
6 organisations have only inactive Type II DMFs for Etoposide. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Etoposide have a European Certificate of Suitability?
Yes. 6 organisations hold a valid CEP for Etoposide on the EDQM register, including TAPI NL B.V. Amsterdam (NL), SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou (CN), MAC CHEM PRODUCTS (INDIA) PRIVATE LIMITED Mumbai (IN), CIPLA LIMITED Mumbai (IN), JIANGSU HENGRUI PHARMACEUTICALS CO., LTD. Lianyungang (CN) and NIPPON KAYAKU CO., LTD. Tokyo (JP). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Etoposide supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Etoposide?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.